ARTEC's technology is built upon patented methods for differentiating pluripotent stem cells into Natural Killer (NK) cells, as well as proprietary modifications of these NK cells to enhance their effectiveness in combating cancers. One example of such modification is the alteration of checkpoint receptors, as demonstrated below.